Business Review (2010-7-9)
GlaxoSmithKline Review Supports Avandia, FDA To Review Data
GlaxoSmithKline Review Supports Avandia, FDA To Review Data
World Business Review – Personnel Decisions
HARVARD BUSINESS REVIEW MONEY STRATEGIES MOBILITY RISK
$13.45
HARVARD BUSINESS REVIEW APRIL 2007
$5.60
Wiley Cpa Exam Review 2008 Business Environment and …
$28.95
Finance (Barron’s business review series) Ehsan Nikbakh
$2.00
Harvard Business Review on the Tests of a Leader by [...]